Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Spanyolország

In Spanyolország 34 Also abroad 559

34 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

No phaseTaking people
Comprehensive Maintenance Program: a Health Haven for COPD in Lleida.The NAPOLEON Project.
Where
Lleida
Életkor
40 év to 75 év
People
86
Run by
Institut de Recerca Biomèdica de Lleida
See details and how to joinNCT07394712
No phaseNot yet taking people in Spanyolország
Effectiveness and Efficiency of Home Telemonitoring and Non-invasive Ventilation in Patients With COPD and Hypercapnia (EVALECO)
Where
Madrid
Életkor
50 év to 90 év
People
92
Run by
Air Liquide Healthcare Spain
See details and how to joinNCT07679646
2. fázisNot yet taking people in Spanyolország
The MAB Trial: A Study of Tozorakimab to Reduce Lung Inflammation and Promote Lung Healing in People with COPD.
Where
Barcelona, Palma
Életkor
18 év and over
People
60 worldwide
Run by
University Of Leicester
See details and how to join2025-522359-24-00 · EU 2025-522359-24-00
3. fázisTaking people
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Where
Madrid, San Cristóbal de La Laguna, Seville, Vigo
Életkor
18 év to 80 év
People
40 worldwide
Run by
Grifols Therapeutics LLC
See details and how to joinNCT07555483 · EU 2025-522792-29-00
2. fázisTaking people
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Where
Benalmádena, Granollers, Madrid, Málaga, Mérida, Pozuelo de Alarcón, Santander
Életkor
40 év and over
People
987 worldwide
Run by
AstraZeneca
See details and how to joinNCT07082738
3. fázisTaking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Where
Badalona, Barcelona, Chamberí, Madrid, Santander, Zaragoza
Életkor
40 év to 80 év
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00
2/3. fázisTaking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Where
Barcelona, Benalmádena, Granada, Málaga, Mérida, Pozuelo de Alarcón, Santander, Zaragoza
Életkor
35 év to 80 év
People
1156 worldwide
Run by
Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00
4. fázisTaking people
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Where
Barcelona, Madrid, Oviedo, Pozuelo de Alarcón, Santander
Életkor
40 év to 85 év
People
218 worldwide
Run by
Sanofi
See details and how to joinNCT07053423
3. fázisTaking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Where
Benalmádena, Cáceres, Jerez de la Frontera, L'Hospitalet de Llobregat, Málaga, Mérida, Palma, Seville
Életkor
40 év to 80 év
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190209 · EU 2024-518016-39-00
4. fázisTaking people
This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization
Where
Cáceres, Girona, Granada, Santander, Santiago de Compostela
Életkor
40 év and over
People
754 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT07587658 · EU 2025-524392-23-00
2. fázisNot yet taking people in Spanyolország
A Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants with COPD
Where
Badalona, Barcelona, Benalmádena, Granada, Madrid, Pamplona, Torrelavega, Vic, Zaragoza
Életkor
18 év and over
People
183 worldwide
Run by
Expedition Therapeutics Inc.
See details and how to join2026-525216-34-00 · EU 2026-525216-34-00
3. fázisTaking people
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Where
Alzira, Barcelona, Benalmádena, Ferrol, Galdakao, Madrid, Málaga, Marbella, Palma, Pamplona, Pozuelo de Alarcón, Santander, Sevilla, Zaragoza
Életkor
40 év to 80 év
People
981 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06959095 · EU 2024-520418-22-00
3. fázisTaking people
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Where
Alicante, Barakaldo, Barcelona, Cabra, Cantabria, Granada, Illes Balears, Madrid, Málaga, Marbella, Mataro, Santa Cruz de Tenerife, Santiago de Compostela, Valencia
Életkor
40 év to 80 év
People
5250 worldwide
Run by
AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00
No phaseTaking people
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Where
Valencia
Életkor
40 év to 80 év
People
200 worldwide
Run by
Pulmonx Corporation
See details and how to joinNCT06035120
No phaseTaking people
Medical Device Clinical Trial Without CE Marking to Evidence Safety and Performance of the INBENTUS VERSATILE Ventilator in Patients Requiring Assisted/Controlled Mechanical Ventilation and Weaning.
Where
Murcia
Életkor
18 év and over
People
81
Run by
Iconic Solutions By Murcia SL
See details and how to joinNCT07432191
3. fázisTaking people
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Where
Barakaldo, Barcelona, Granada, Madrid, Málaga, Palma, Pamplona, Sevilla, Valencia
Életkor
40 év to 80 év
People
990 worldwide
Run by
AstraZeneca
See details and how to joinNCT06883305 · EU 2024-517458-90-00
No phaseNot yet taking people in Spanyolország
Extracorporeal Carbon Dioxide Removal Plus Noninvasive Ventilation in Patients With COPD Not Eligible for Intubation
Where
Barcelona
Életkor
18 év and over
People
14
Run by
Hospital del Mar Research Institute (IMIM)
See details and how to joinNCT07785375
2. fázisTaking people
A study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease
Where
Benalmádena, Granollers, Madrid, Málaga, Mérida, Pozuelo de Alarcón, Santander
Életkor
18 év and over
People
307 worldwide
Run by
AstraZeneca AB
See details and how to join2025-520473-40-00 · EU 2025-520473-40-00
3. fázisTaking people
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Where
Alcalá de Henares, Alzira, Barcelona, Benalmádena, Lleida, Madrid, Málaga, Palma, Pontevedra, Valladolid
Életkor
40 év to 75 év
People
1196 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00
4. fázisTaking people
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
Where
Barcelona, Palma de Mallorca
Életkor
40 év and over
People
135 worldwide
Run by
Maria Joyera Rodríguez
See details and how to joinNCT06334575
1. fázisNot yet taking people in Spanyolország
An Open Label Study to Assess the Effect of Patient Use and Robustness on Tiotropium Bromide Spray 2.5μg, Soft Mist Inhaler device
Where
Almería, Barcelona, L'hospitalet De Llobregat, Madrid, Salamanca, Santander, Sevilla, Valencia
Életkor
18 év and over
People
75
Run by
Laboratorios Liconsa S.A.
See details and how to join2025-522412-16-00 · EU 2025-522412-16-00
No phaseNot yet taking people in Spanyolország
EFFECTIVENESS OF COMBINED CONCENTRIC AND ECCENTRIC AEROBIC EXERCISE ON A TREADMILL IN PATIENTS WITH COPD: A RANDOMIZED CLINICAL TRIAL.
Where
Madrid
Életkor
18 év and over
People
40
Run by
Universidad Europea de Madrid
See details and how to joinNCT07627035
No phaseTaking people
The CATALINA Study
Where
Barcelona
Életkor
18 év and over
People
1000 worldwide
Run by
Wim Janssens
See details and how to joinNCT05008081
No phaseNot yet taking people in Spanyolország
Multidimensional Study of Dyspnea at Rest, During Exertion, Self-induced Through a Virtual Reality Scenario, and Its Placebo Effect in Patients With COPD and Control Subjects.
Where
San Sebastián
Életkor
18 év and over
People
80
Run by
University of Deusto
See details and how to joinNCT07568379
4. fázisTaking people
Molecular signatures associated with response to ICS treatment in patients with COPD stratified by eosinophil levels
Where
Barcelona, Palma
Életkor
18 év to 64 év
People
60 worldwide
Run by
Fundacio De Recerca Clinic Barcelona-Institut D’investigacions Biomediques August Pi I Sunyer
See details and how to join2023-505245-13-00 · EU 2023-505245-13-00